Synta Announces Encouraging Results of Ganetespib GALAXY-1 Trial at ECC 2013
September 28, 2013 at 09:26 AM EDT
Synta Pharmaceuticals (NASDAQ: SNTA ) today announced presentation of results from the GALAXY-1 trial, a global, randomized, multi-center Phase 2b/3 study designed to identify the patients with advanced
